Evidence map›Paper›PMID 33482742›Full record

ArticleBMC infectious diseases2021

Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler.

W Evan Johnson, Aubrey Odom, Chelsie Cintron, Mutharaj Muthaiah, Selby Knudsen, Noyal Joseph, Senbagavalli Babu, Subitha Lakshminarayanan, David F Jenkins, Yue Zhao and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Monocyte-Amplified Transcriptional Signatures of Human Diseases.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

W Evan Johnson *Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA. wej@bu.edu.ORCID http://orcid.org/0000-0002-6247-6595
Aubrey Odom *Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
Chelsie CintronBoston Medical Center, Boston, MA, USA.
Mutharaj MuthaiahGovernment Hospital for Chest Diseases, Puducherry, India.
Selby KnudsenBoston Medical Center, Boston, MA, USA.
Noyal JosephJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Senbagavalli BabuJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Subitha LakshminarayananJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
David F JenkinsDivision of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
Yue ZhaoDivision of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
Ethel NankyaDivision of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA.
C Robert HorsburghDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Gautam RoyJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Jerrold EllnerDepartment of Medicine, Center for Emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Sonali SarkarJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Padmini Salgame *Department of Medicine, Center for Emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, USA.
Natasha S Hochberg *Boston Medical Center, Boston, MA, USA.
Boston University · USJawaharlal Institute of Post Graduate Medical Education and Research · INBoston Medical Center · USRutgers, The State University of New Jersey · US

Funding

Removing batch effects in high-throughput biomedical studiesR01GM127430 · NIGMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI William Evan Johnson · 2018 to 2026
$2.4M
Signature of profiling and staging the progression of TB from infection to disease.R21AI154387 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOHNSON, WILLIAM EVAN · 2020 to 2021
$468k
Microbiome-based biomarkers and models of lung cancer development and treatmentR21CA260382 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JOHNSON, WILLIAM EVAN, SEGRE, DANIEL · 2022 to 2023
$377k
NCI NIH HHS R21 CA260382NIAID NIH HHS R21 AI154387NIGMS NIH HHS R01 GM127430NIH HHS R01GM127430-02NSF 1559829US Civilian Research and Development Foundation 62909, 16963
6 · The paper itself

Abstract

backgroundGene expression signatures have been used as biomarkers of tuberculosis (TB) risk and outcomes. Platforms are needed to simplify access to these signatures and determine their validity in the setting of comorbidities. We developed a computational profiling platform of TB signature gene sets and characterized the diagnostic ability of existing signature gene sets to differentiate active TB from LTBI in the setting of malnutrition.

methodsWe curated 45 existing TB-related signature gene sets and developed our TBSignatureProfiler software toolkit that estimates gene set activity using multiple enrichment methods and allows visualization of single- and multi-pathway results. The TBSignatureProfiler software is available through Bioconductor and on GitHub. For evaluation in malnutrition, we used whole blood gene expression profiling from 23 severely malnourished Indian individuals with TB and 15 severely malnourished household contacts with latent TB infection (LTBI). Severe malnutrition was defined as body mass index (BMI) < 16 kg/m2 in adults and based on weight-for-height Z scores in children < 18 years. Gene expression was measured using RNA-sequencing.

resultsThe comparison and visualization functions from the TBSignatureProfiler showed that TB gene sets performed well in malnourished individuals; 40 gene sets had statistically significant discriminative power for differentiating TB from LTBI, with area under the curve ranging from 0.662-0.989. Three gene sets were not significantly predictive.

conclusionOur TBSignatureProfiler is a highly effective and user-friendly platform for applying and comparing published TB signature gene sets. Using this platform, we found that existing gene sets for TB function effectively in the setting of malnutrition, although differences in gene set applicability exist. RNA-sequencing gene sets should consider comorbidities and potential effects on diagnostic performance.

Indexed as

SoftwareAdolescentAdultAgedArea Under CurveBiomarkersChildComorbidityFemaleGene Expression ProfilingHumansLatent TuberculosisMaleMalnutritionMiddle AgedMycobacterium tuberculosisBiomarkersBiomarkersGene setsLatent tuberculosis infectionMalnutritionRNA-sequencingSignaturesTuberculosis

Identifiers

PMID33482742
PMCPMC7821401
OpenAlexW3121985000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.